Finanzwire Finanzwire
Basculer en Français
10812 Companies
234244 Keywords
163039 Articles
125257 Press releases
Headlines Articles Press releases AL-S Pharma AG Remove
  1. Home
  2. Companies
  3. AL-S Pharma AG
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 06/24/2026 at 17:25, 1 month 13 days ago

    AL-S Pharma Reports Positive AP-101 Phase 2 Findings for ALS Treatment

    Clinical Trial ALS Treatment Phase 2 Data SOD1 Misfolding AP-101 Antibody
  • PRESS RELEASE

    published on 06/24/2026 at 17:20, 1 month 14 days ago

    AL-S Pharma Presents AP-101 Phase 2 Data Supporting Misfolded SOD1 as a Therapeutic Target in ALS at ENCALS 2026

    AL-S Pharma presents Phase 2 data on AP-101 supporting misfolded SOD1 as ALS therapeutic target at ENCALS 2026. Key study results and clinical implications discussed
    ALS Phase 2 Data SOD1 AL-S Pharma ENCALS 2026
    Logo of AL-S Pharma AG
  • BRIEF

    published on 03/19/2026 at 07:35, 4 months 20 days ago

    AL-S Pharma's AP-101 Shows Promise in ALS Treatment

    Clinical Trial ALS Treatment Phase 2 Data AP-101 SOD1 Targeting
  • PRESS RELEASE

    published on 03/19/2026 at 07:30, 4 months 20 days ago

    Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS

    AL-S Pharma AG presents additional Phase 2 data of lead program AP-101 at AD/PD International Conference showing disease modification in ALS patients. AP-101 targets misfolded SOD1 to inhibit disease progression
    ALS Phase 2 Data AP-101 AL-S Pharma AG SOD1
    Logo of AL-S Pharma AG
Accesswire
  • Published on 08/08/2026 at 00:00, 17 hours 24 minutes ago

    Boron One Announces Change of Auditor

  • Published on 08/07/2026 at 23:15, 18 hours 9 minutes ago

    Faraday Copper Reports Second Quarter 2026 Financial Results

  • Published on 08/07/2026 at 23:00, 18 hours 24 minutes ago

    Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing

  • Published on 08/07/2026 at 22:30, 18 hours 54 minutes ago

    UraniumX Deploys $3.8 Million to Athabasca Basin Exploration

  • Published on 08/07/2026 at 22:15, 19 hours 9 minutes ago

    Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services

View all ACCESSWIRE
EQS Group
  • Published on 08/08/2026 at 16:25, 59 minutes ago

    Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort

  • Published on 08/07/2026 at 23:21, 18 hours 3 minutes ago

    EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration

  • Published on 08/07/2026 at 19:30, 21 hours 54 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 08/07/2026 at 19:15, 22 hours 9 minutes ago

    ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries

  • Published on 08/07/2026 at 18:10, 23 hours 14 minutes ago

    Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request

View all EQS
Les Echos
  • Published on 08/07/2026 at 18:54, 22 hours 30 minutes ago

    Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026

  • Published on 08/07/2026 at 18:40, 22 hours 44 minutes ago

    Disclosure of transactions in own shares from August 3 to August 7, 2026

  • Published on 08/07/2026 at 17:49, 23 hours 35 minutes ago

    Crédit Agricole CIB announced the publication of the Amendment of its 2025 Universal Registration Document

  • Published on 08/07/2026 at 08:30, 1 day 8 hours ago

    Disclosure of shares outstanding and voting rights - 07.08.2026

  • Published on 08/06/2026 at 18:26, 1 day 22 hours ago

    Air Liquide voting rights as of July 31st 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy